The transcriptional activator LAC9, a GAL4 homolog of Kluyveromyces lactls which mediates lactose and galactose-dependent activation of genes involved in the utilization of these sugars can also confer glucose repression to those genes. Here we report on the Isolation and characterization of LAC9-2, an allele which encodes a glucose-sensitive activator in contrast to the one previously cloned. A single amino acid exchange of leu-104 to tryptophan is responsible for the glucose-insensitive phenotype. The mutation is located within the Zn-finger-like DNA binding domain which is highly conserved between LAC9 and GAL4. Glucose repression is also eliminated by duplication of the LAC9-2 allele. The data Indicate that LAC9 is a limiting factor for /3-galactosidase gene expression under all growth conditions and that glucose reduces the activity of the activator.
INTRODUCTION
When yeast cells are grown in glucose-containing media the expression of a large number of genes including those involved in disacchande utilization is shut off or greatly reduced. This phenomenon has been termed glucose repression or catabolite repression after an analogous situation in Escherichia coli (1) but the molecular mechanism in yeast is clearly different (2, 3) -A large number of mutants have been isolated in Saccharomyces cerevisiae which affect this process (see (4, 5) for reviews) but the intracellular signal induced by glucose and its transmission to the transcriptional machinery are points which are still not understood. Only for the last step in the signal transduction chain, the regulation of transcription in response to glucose, are molecular details beginning to emerge for a few genes, revealing a large complexity in the mechanisms.
For example, glucose repression of the ADH2 gene encoding alcohol dehydrogenase involves phosphorylation of the transcription factor ADR1 (6, 7) . At least part of this phosphorylation depends on a cAMP-dependent protein kinase. Thus, cAMP stimulates repression in contrast to the situation in E. coli in which catabolite repression is relieved by high cAMP levels.
Expression of the cytochrome c gene CYC1 is limited in the presence of glucose by the availability of the transcription factor HAP4, the synthesis of which is regulated at the transcriptional level. HAP4 binds to UAS2 of the CYCJ promoter in a complex with HAP2 and HAP3 and is most likely responsible for the derepression of the gene in the absence of a fermentable carbon source (8) . Induction of the gene in response to oxygen is controlled by different transcription factors, HAP1 and RC2 which bind to the adjacent UAS1 element (9) .
Here we present an example in which a single transcription factor LAC9 responds to both the signal generated by the inducer and that generated by the presence of glucose. LAC9 regulates genes involved in lactose metabolism of the milk yeast Kluyveromyces lactis. Like the utilization of the disaccharide melibiose in S. cerevisiae ((10), see (11) for a review on the S. cerevisiae GAL regulon), lactose metabolism in K. lactis is closely linked to that of galactose and both sugars cause induction of gene expression (12) (13) (14) . LAC9 is the K. lactis homolog of GAL4 as evident from the fact that it can complement a gal4 mutation of S. cerevisiae (15) and vice versa (16) . Both proteins bind to similar DNA sequences with the conserved motif 5'-CGG-N 5 TN 5 -CGG-3' (17, 18) , and the amino acid sequence deduced from the cloned genes revealed three homologous domains one of which is involved in DNA binding (15, 19) .
The LAC genes of K. lactis LAC12 and LAC4, encoding lactose permease and /3-galactosidase, respectively (20, 21) , each contain two LAC9 binding sites in their 5' non-coding region located between the divergently transcribed genes (18, 22) our unpublished data). Deleting the LAC9 gene not only eliminates transcnptional activation of the LAC and GAL genes but also eliminates the basal level of LAC4 gene expression ( (22) Godecke et al., in preparation). Thus, LAC9 also activates transcription of LAC4 in the absence of the inducer to about 1 % of the fully induced levels.
LAC9 is synthesized constitutively and is able to bind to DNA when extracted from cells grown under non-inducing conditions (18, 23) . Genetic evidence suggests (24, 25) that as in GAL4, the activating function may be regulated by a trans-acting negative factor which itself is inactivated by the inducer, probably a metabolite of galactose. Since LAC9 can interact with GAL80 (26) the negative regulator of K. lactis may function in a similar way.
Only in some of the natural K. lactis isolates are the LAC genes subject to glucose repression, and it has been shown recently that the transcriptional activator LAC9 is the target of the glucose
• To whom correspondence should be addressed (3-galactosidase assay: Cells were grown in yeast nitrogen base (YNB) containing all amino acids (28) and 2 % glucose to midlog phase, harvested and diluted to an ODgoo of about 0.3 into fresh medium containing 2% glucose and 2% galactose. Cell extracts were prepared by breaking the cells with glass beads in a Braun homogenizer (Braun, Melsungen) as described (23) . Protein concentration was determined according to Lowry (38) and j3-galactosidase activity was measured using o-nitrophenyl-/3-D-galactoside (30mM) as substrate. Activities were expressed as nmoles of substrate converted per min at 37°C and were determined in at least three independent experiments. Standard deviations were around 20%.
RESULTS

Cloning of the LAC9-2 gene
Induced (3-galactosidase activities in K. lactis strain JA6 are decreased about 50-fold by the presence of glucose (23) . In contrast, only a 2-fold reduction by glucose is seen with strain Y1140 (12) and with JA6-1, a strain isogenic to JA6, but harbouring the LAC9 gene of Yl 140 (23) . Hence the difference has to be due to the LAC9 allele and we set out to isolate the LAC9 gene of JA6 (LAC9-2). We used the cloned LAC9-1 gene of strain Y1140 (15) for integrative cloning (39) following the strategy outlined in Figure 1 To avoid resequencing of the 2.6 kb gene we used nuclease SI treatment of heteroduplexes to detect differences between the two alleles. Two labeled fragments covering the 5' and 3' part of the LAC9-2 gene, respectively, were isolated and each was hybridized to an excess of linearized and denatured plasmid pj-LAC9 (15) initial assay conditions, additional differences between the two genes could not be excluded. We therefore examined if either of these mutations or both together were responsible for the glucose repressible phenotype of the LAC9-2 strain JA6. A mutation in the Zn-finger of LAC9 is responsible for the glucose-repressible ptienotype. First we introduced both mutations into LAC9-2 by exchanging the 409 bp fragment we had sequenced (for details see Materials and methods). The resulting LAC9-AJ2 gene had the LAC9-1 sequence at the indicated positions in the LAC9-2 allele. This LAC9-A12 allele was used to transplace lac9::URA3 in strain DL9, the Iac9~ derivative of JA6 (18) . As a control a similar replacement was performed with the original LAC9-2 allele leading to strain JA6-A2. /3-Galactosidase measurements demonstrated that JA6-A2 as well as JA6 were glucose repressed whereas the new strain JA6-A12 is clearly inducible in the presence of glucose (Figure 4 ). Therefore, one or both mutations on the transplaced fragment had to be responsible for the LAC9-J phenotype.
To separate the two mutations we changed the leucine codon of LAC9-2 (amino acid 104) to tryptophan by site-directed mutagenesis giving LAC9-J04. Again this allele was introduced into DL9 by transplacement and the resulting strain was named JA6-104. As also shown in Figure 4 this strain behaved in almost exactly the same way as JA6-A12. We could conclude that the Trp-103 residue caused the glucose insensitive-phenotype of LAC9-1 whereas the insertion of the Asn codon had no significant effect.
Interestingly amino acid 103/104 is located in the Zn-finger which represents part of the DNA binding domain (40) of LAC9. This region is well conserved between LAC9 and GAL4 of 5. cerevisiae ( Figure 3 bottom and (41) . GAL4 contains a leucine residue at the corresponding position of its Zn-finger, just like the repressible LAC9-2 protein had been shown to confer glucose repression to LAC4 gene expression when it was introduced into K.lactis substituting LAC9 function (16) .
Slight overproduction of LAC9-2 overrides glucose repression
The dominance or recessiveness of the glucose repressible phenotype should give some clue to the potential mechanism. Since K.lactis is unstable as a diploid we decided to introduce two LAC9 genes into a haploid cell. Using the otherwise isogenic Figure 5A . The Southern blot ( Figure 5B ) shows that not more than one plasmid copy had been integrated since the intensity of the HindUl fragment of 2.7 kb and 3.1 kb resulting from plasmid and flanking sequences, respectively, were about the same. /3-Galactosidase activity was followed after addition of galactose to glucose-grown cells ( Figure 5C ). In all strains containing two LAC9 genes (only three of the four possible combinations are shown) there was no glucose repression. The effect of glucose was even less than in JA6-1, the so-called non-repressible strain which showed a slightly longer delay at the onset of induction and clearly lower induced enzyme levels. Surprisingly, there was no difference in the kinetics of induction between strains having two LAC9-2 (JA6-2/2) or two LAC9-1 genes (JA6-1/1) but the latter one showed elevated level of /3-galactosidase throughout the time course. JA6-2/2 was identical to strains JA6-1/2 (not shown) and JA6-2/1, leading to the conclusion that an increase in gene dosage from one to two is sufficient to override glucose repression and the glucose insensitive allele had no additional effect under conditions of LAC9 overproduction.
Strains containing two LAC9 genes also had higher basal levels of LAC4 gene expression. Under repressed conditions strain JA6-2/2 gave 5-10 fold higher /3-galactosidase activities than JA6. In JA6-1/1 the basal level was about 60% of the normal induced level. These data indicate that LAC4 gene expression is limited by the amount of active LAC9 protein both in the presence and in the absence of inducer. As pointed out earlier the LAC9-1 allele present in a single copy also results in higher enzyme activities on glucose (23) .Thus, in all strains there is a correlation between the glucose insensitive phenotype and an elevated level of/3-galactosidase in glucose grown cells suggesting that glucose acts by negatively affecting the activity of the transcriptional activator LAC9.
DISCUSSION
We have cloned and analysed LAC9-2, a second allele of the gene encoding the transcriptional activator LAC9. The product of this allele confers sensitivity to glucose. Two differences to the previously cloned LAC9-1 allele (15) were detected, a 5'-AAC-3' insertion and a G-T transversion . The latter is responsible for the phenotype as shown by site-directed mutagenesis and changes amino acid 103 of LAC9-1 (104 of LAC9-2) from tryptophan to leucine. The 3 bp insertion does not seem to affect the properties of LAC9 that were tested here. It extends a stretch of eight asparagines (aminoacids 77 to 84 of LAC9-1) by one and might be a consequence of slippage by the replication machinery on this stretch of AAC-codons. Using SI nuclease search for allelic differences, the relevant mutation was initially detected only fortuitously by being linked to a 3 bp insertion. However, later on we were able to cleave the single mismatched basepair using higher concentrations of SI.
The mutation conferring glucose sensitivity is located within the Zn-finger sequence motif highly conserved between LAC9 and GAL4 (15, 19) that has been shown to be involved in DNA binding in both proteins (40, 42) . The Trp-Leu exchange increases the homology to GALA which also has a Leu-codon at the corresponding position. As a consequence within a stretch of 14 residues 13 are identical between LAC9-2 and GA14. Interestingly, GALA also confers glucose repression to the LAC genes when introduced into K. lactis (16) . Therefore, the mechanism of glucose repression of the GAL genes which involves the GAL4 protein is probably similar in S. cerevisiae and K. lactis. However, in 5. cerevisiae additional GAL4 independent pathways of repressing the GAL genes exist (43 -45) which might explain why glucose insensitive variants of GAL4 have escaped detection until now.
Not only strains containing the LAC9-1 allele are nonrepressible by glucose but also those containing a duplication of the LAC9 gene, including the one with two copies of LAC9-2 encoding the glucose sensitive activator. By quantitating LAC9 binding activity in crude cell extracts of JA6-2/2 we have observed a 2 and 4 -5 fold higher activity in glucose-or galactose-grown cells, respectively (Zachariae and Breunig, in preparation). Thus, a moderate overproduction of the activator is sufficient to overcome the inhibiting effect of glucose. The elevated /3-galactosidase levels in these strains indicate that LAC9 activity is rate limiting for LAC4 gene expression under all growth conditions. The higher basal levels of enzyme activity in the haploid strains JA6-1 (23) and JA6-A12 as compared to JA6 or JA6-A2 suggests that the LAC9-1 protein present in these strains has a higher activity. The correlation of elevated basal levels of LAC4 expression with a glucose-insensitive phenotype further suggests that glucose acts by reducing the activity of LAC9. LAC9-1 would then be a variant which is less sensitive to the inhibitory effect of glucose.
How could the glucose signal influence the activity of the activator? In principle its potential to activate transcription, its ability to bind to DNA or both activities could be affected. At present we cannot rule out any of these possibilities. However, based on the finding that a point-mutation in the Zn-finger renders the protein largely insensitive to glucose we would like to suggest that the DNA-binding rather than the activating function of LAC9 is affected by glucose. In keeping with this proposal it has been observed that in S. cerevisiae cells the characteristic GAL4-dependent m vivo footprint is absent in glucose grown cells (46) (47) (48) indicating that binding of the activator is affected by glucose. Regulation of DNA binding could occur in two ways: First, in glucose the LAC9 target site could be inaccessible e.g because another protein binds to the same region. In the glucose-insensitive strains LAC9 could then serve as a better competitor either by having a higher affinity for DNA or by being present in higher concentrations. Although a gal4 mutant in which the Leu-19 corresponding to Leu-104 in LAC9-2 was converted to a proline indeed had drastically reduced binding activity (49) preliminary results did not reveal any differences in DNA affinity between LAC9-1 and LAC9-2 (unpublished observations). In addition, a protein binding to DNA with about the same affinity as LAC9 should be detectable in our in vitro binding studies and we do not have any evidence for that. In particular in a strain lacking LAC9 no footprint is seen (18) . Also the in vivo studies in 5. cerevisiae (47, 48) do not give any indication that another protein is replacing GAL4 in glucose-grown cells. The protein involved in chromatin organization which binds to the same region does not seem to be regulated nor does it prevent GAL4 from binding (50) . We therefore consider this first model unlikely.
In the second model the LAC9 protein itself is modified in glucose. This could either occur by a regulated post-translational modification or by complex formation with a protein or metabolite generated in the presence of glucose. Covalent modification has been reported for GAL4 (51) . GAL4 gets phosphorylated and at least one phosphorylated form is correlated with its highly active state. Upon addition of glucose this form disappears. However, it has not been shown yet that dephosphorylation is responsible for inactivation. If phosphorylation were to account for regulation of LAC9 activity by glucose, then LAC9-1 should be phosphorylated at least to the same extent as LAC9-2, since it is as active, but should be more resistant to dephosphorylation. In the overproducing strains a higher level of the phosphorylated highly active form might account for the glucose-insensitive phenotype although the idea that a phosphatase activity is limiting is not very likely. The same argument applies to a metabolite accumulating in glucose grown-cells.
In contrast, a protein synthesized or activated in response to the glucose signal could be present at limiting concentrations accounting for the 'titration' effect seen in LAC9 overproducing strains. LAC9-1 would then have a lower affinity for such a hypothetical 'glucose repressor'. This protein could bind to LAC9 preventing it from binding to DNA or it could bind to the LAC9/DNA complex destabilizing it or preventing activation of transcription. By comparing LAC9-2 DNA binding activity in extracts from glucose and galactose grown cells we observed a difference of only 2-3 (Zachariae and Breunig, unpublished). However, the postulated complex might dissociate under our conditions of extract preparation (18) and not be able to reform with the DNA-free LAC9 protein. Alternatively the activity of the repressor might be regulated by phosphorylation. Since we have a strong phosphatase activity in our extracts such a modification may be lost.
The regulation of DNA binding by glucose as proposed for LAC9 is opposed to the effect of lactose and galactose which seem to regulate the transcription activating function. Recently Kim and Guarente (52) suggested that the Zn-finger of the transcriptional activator HAP1 is not only involved in DNA binding but also in transcriptional activation. It may turn out to be more generally true that these two functions are not as independent as current models imply. Further analysis of the two forms of LAC9 should allow to determine whether this activator is really composed of two separate domains which are independently regulated or whether both functions are structurally linked.
